Home › Type 1 Diabetes › Washington
Pag-aaral pangklinika para sa Type 1 Diabetes sa Washington
20 pag-aaral para sa Type 1 Diabetes ang naghahanap ng mga kalahok sa mga site sa Washington.
Mga Lungsod sa Washington
Opisyal na teksto ng pag-aaral (English)
Type 1 Diabetes Extension Study
- Benaroya Research Institute, Seattle
Nagre-recruitObservasyonal na pag-aaral
Edad 8 hanggang 35 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT02734277METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Nagre-recruitPhase 2
Edad 18 hanggang 69 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07699380A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle
- MultiCare Mary Bridge Children's Health Center- Site Number : 8400037, Tacoma
Nagre-recruitPhase 3
Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- Benaroya Research Institute, Seattle
- University of Washington Diabetes Institute, Seattle
Nagre-recruitPhase 1/2
Edad 12 hanggang 35 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06783309Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- Benaroya Research Institute, Seattle
Nagre-recruitPhase 2
Edad 4 hanggang 34 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- Benaroya Research Institute, Seattle
Nagre-recruitPhase 2
Edad 8 hanggang 45 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- Seattle Children's Hospital, Seattle
Nagre-recruitPhase 1/2
Edad 9 hanggang 20 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07061574SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason, Seattle
- Mary Bridge Children's Outpatient Center - Tacoma, Tacoma
Nagre-recruitPhase 2
Edad 5 hanggang 40 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT07187531Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
- University of Washington, Seattle
Nagre-recruit
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hul 16, 2026 · NCT06880835Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 2, 2026 · NCT05822609Kidney Precision Medicine Project
- University of Washington, Seattle
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 14, 2026 · NCT04334707Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
- Rainier Clinical Reseach Center, Renton
Nagre-recruit
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Abr 9, 2026 · NCT07296276Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
- Rainier Clinical Research Center, Renton
Nagre-recruitPhase 2
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Abr 6, 2026 · NCT06964087Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT06217302Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Nagre-recruitPhase 3
Edad 18 hanggang 49 · Lahat ng kasarian · Na-update Mar 4, 2026 · NCT05819138Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
- Seattle Children's, Seattle
Nagre-recruit
Edad 16 hanggang 19 · Lahat ng kasarian · Na-update Dis 30, 2025 · NCT07292558EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
- Benaroya Research Institute, Seattle
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 70 · Lahat ng kasarian · Na-update Dis 19, 2025 · NCT03369821InvesT1D: Promoting Adolescent Investment in Diabetes Care
- Seattle Children's, Seattle
Nagre-recruit
Edad 12 pataas · Lahat ng kasarian · Na-update Dis 16, 2025 · NCT06384911TrialNet Pathway to Prevention of T1D
- Benaroya Research Institute, Seattle
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 45 · Lahat ng kasarian · Na-update Hul 1, 2025 · NCT00097292MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
- Seattle Children's Hospital, Seattle
Nagre-recruitPhase 1
Edad 12 hanggang 25 · Lahat ng kasarian · Na-update Hun 13, 2025 · NCT05065372Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.